Kiora Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Kiora Pharmaceuticals

15/11/2021 22:01

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported a quarterly
adjusted loss of 29 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 34 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Kiora Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 29 cents​.
* The mean earnings estimate of analysts had risen by
about 12.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kiora Pharmaceuticals Inc shares had fallen by 34.2% this
quarter and lost 70.0% so far this year.
* The company reported a quarterly loss of $2.97 million.
* Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $11.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated